Skip to main content

ICU Delirium in the Era of the COVID-19 Pandemic

  • Chapter
  • First Online:
Annual Update in Intensive Care and Emergency Medicine 2021

Part of the book series: Annual Update in Intensive Care and Emergency Medicine ((AUICEM))

Abstract

The coronavirus disease 19 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a public health threat worldwide since December 2019. Apart from respiratory system involvement and systemic critical illness it has become obvious that SARS-CoV-2 can cause acute brain dysfunction in the form of delirium. Data have shown that delirium occurs in 45–84% of COVID-19 patients, may be the first presenting symptom, and leads to a worse prognosis. Increased risk factors for delirium are associated with medical management (sedative strategies to aid mechanical ventilation in patients with acute respiratory distress syndrome [ARDS], prolonged mechanical ventilation, prone positioning, immobilization), neurotrophic potential of the virus (direct central nervous system invasion, induction of inflammatory response mediators, multiple organ and system failure) and organizational issues (isolation from relatives and friends). Despite a heavy workload and multiple clinical challenges, the standard of care for critically ill patients, including delirium screening, prevention and management, should remain at the highest possible level, with the guidance of the ABCDEF bundle. Thorough assessment to identify ICU delirium and appropriate clinical management is necessary to limit its duration and severity. In this chapter, we discuss the epidemiology and risk factors for delirium in intensive care unit (ICU) patients, as well as identifying the sources of ICU delirium amidst the COVID-19 pandemic to help healthcare professionals limit the burden. Issues related to the post-COVID syndrome and post-intensive care syndrome (PICS) are also highlighted. Future research should concentrate on the understanding of the pathobiology of the virus and its neurotrophic potential to develop protective strategies for this and future coronavirus pandemics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. General’s opening remarks at the media briefing on COVID-19. Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020. Accessed 13 May 2021.

  2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.

    Article  CAS  PubMed  Google Scholar 

  3. Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24:176.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zazzara MB, Penfold RS, Roberts AL, Lee KA, Dooley H, Sudre CH, et al. Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults. Age Ageing. 2021;50:40–8.

    Article  PubMed  Google Scholar 

  5. Rebora P, Rozzini R, Bianchetti A, Blangiardo P, Marchegiani A, Piazzoli A, et al. CoViD-19 Lombardia team. Delirium in patients with SARS-CoV-2 infection: a multicenter study. J Am Geriatr Soc. 2021;69:293–9.

    Article  PubMed  Google Scholar 

  6. World Health Organization and International Severe Acute Respiratory and Emerging Infection Consortium. COVId-19 Core Case Report Form. Available at: https://media.tghn.org/medialibrary/2020/05/ISARIC_WHO_nCoV_CORE_CRF_23APR20.pdf. Accessed 18/5/21.

  7. Kotfis K, Williams Roberson S, Wilson J, Pun B, Ely EW, Jeżowska I, et al. COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic? Anaesthesiol Intensive Ther. 2020;52:132–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–90.

    Article  PubMed  Google Scholar 

  9. Khan SH, Lindroth H, Perkins AJ, Jamil Y, Wang S, Roberts S, et al. Delirium incidence, duration, and severity in critically ill patients with coronavirus disease 2019. Crit Care Explor. 2020;2:e0290.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–70.

    Article  PubMed  Google Scholar 

  11. Helms J, Kremer S, Merdji H, Schenck M, Severac F, Clere-Jehl R, et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. 2020;24:491.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Jäckel M, Bemtgen X, Wengenmayer T, Bode C, Biever PM, Staudacher DL. Is delirium a specific complication of viral acute respiratory distress syndrome? Crit Care. 2020;24:401.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pun BT, Badenes R, Heras La Calle G, Orun OM, Chen W, Raman R, et al., COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9:239–50.

    Google Scholar 

  14. Xu J, Zhong S, Liu J, Li L, Li Y, Wu X, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41:1089–96.

    Article  CAS  PubMed  Google Scholar 

  15. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Jacomy H, Talbot PJ. Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology. 2003;315:20–33.

    Article  CAS  PubMed  Google Scholar 

  18. Yoshikawa N, Yoshikawa T, Hill T, Huang C, Watts DM, Makino S, et al. Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J Virol. 2009;83:5451–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552–5.

    Article  CAS  PubMed  Google Scholar 

  20. van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;235:277–87.

    Article  PubMed  CAS  Google Scholar 

  21. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130:1787.

    Article  CAS  PubMed  Google Scholar 

  22. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76:3–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007;130:521–34.

    Article  PubMed  Google Scholar 

  26. Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Hawkins M, Sockalingam S, Bonato S, Rajaratnam T, Ravindran M, Gosse P, et al. A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19. J Psychosom Res. 2021;141:110350.

    Article  PubMed  Google Scholar 

  28. Li Z, Liu T, Yang N, Han D, Mi X, Li Y, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14:533–41.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Beach SR, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N, et al. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020;65:47–53.

    Article  PubMed  PubMed Central  Google Scholar 

  30. De Santis G. SARS-CoV-2: a new virus but a familiar inflammation brain pattern. Brain Behav Immun. 2020;87:95–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Li H, Xue Q, Xu X. Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 2020;38:1–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Sher Y, Rabkin B, Maldonado JR, Mohabir P. COVID-19-associated hyperactive intensive care unit delirium with proposed pathophysiology and treatment: a case report. Psychosomatics. 2020;61:544–50.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296:E119–20.

    Article  PubMed  Google Scholar 

  35. Grist JJ, Marro B, Lane TE. Neutrophils and viral-induced neurologic disease. Clin Immunol. 2018;189:52–6.

    Article  CAS  PubMed  Google Scholar 

  36. Howe CL, Lafrance-Corey RG, Sundsbak RS, Lafrance SJ. Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J Neuroinflammation. 2012;9:50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wilson JE, Mart MF, Cunningham C, Shehabi Y, Girard TD, MacLullich AMJ, et al. Delirium. Nat Rev Dis Primers. 2020;6:90.

    Article  PubMed  Google Scholar 

  38. Radmanesh A, Derman A, Lui YW, Raz E, Loh JP, Hagiwara M, et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297:E223–7.

    Article  PubMed  Google Scholar 

  39. Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95:e910–20.

    Article  CAS  PubMed  Google Scholar 

  40. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–27.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Whiteside DM, Oleynick V, Holker E, Waldron EJ, Porter J, Kasprzak M. Neurocognitive deficits in severe COVID-19 infection: case series and proposed model. Clin Neuropsychol. 2021;35:799–818.

    Article  PubMed  Google Scholar 

  42. Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil. 2021;102:155–8.

    Article  PubMed  Google Scholar 

  43. Martillo MA, Dangavach NS, Tabacof L, Spielman L, Dams-O’Connor K, Chan C, et al. Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019 cohort study from a New York City critical care recovery clinic. Crit Care Med. 2021; https://doi.org/10.1097/CCM.0000000000005014. Epub ahead of print.

  44. Cattelan J, Castellano S, Merdji H, Audusseau J, Claude B, Feuillassier L, et al. Psychological effects of remote-only communication among reference persons of ICU patients during COVID-19 pandemic. J Intensive Care. 2021;9:5.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF bundle in critical care. Crit Care Clin. 2017;33:225–43.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825–73.

    Article  PubMed  Google Scholar 

  47. Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Majewski P, et al. COVID-19: pain management in patients with SARS-CoV-2 infection-molecular mechanisms, challenges, and perspectives. Brain Sci. 2020;10:465.

    Article  PubMed Central  CAS  Google Scholar 

  48. Liu K, Nakamura K, Katsukawa HPT, Elhadi M, Nydahl P, Ely EW, et al. ABCDEF bundle and supportive icu practices for patients with coronavirus disease 2019 infection: an international point prevalence study. Crit Care Explor. 2021;3:e0353.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Devlin JW, O’Neal HR Jr, Thomas C, Barnes Daly MA, Stollings JL, Janz DR, et al. Strategies to optimize ICU liberation (A to F) bundle performance in critically ill adults with coronavirus disease 2019. Crit Care Explor. 2020;2:e0139.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

The authors would like to thank Ms. Marta Janowska at www.yanoskyy.pl for help with preparation of the Figures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Kotfis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kotfis, K., Wilson, J.E., Ely, E.W. (2021). ICU Delirium in the Era of the COVID-19 Pandemic. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2021. Annual Update in Intensive Care and Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-73231-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73231-8_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73230-1

  • Online ISBN: 978-3-030-73231-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics